Substrate selectivity of the human RNA m<sup>5</sup>C methyltransferase NSUN2. [PDF]
Canepa J +3 more
europepmc +1 more source
IDMME and IDMDE: inducible CRISPR-dCasRx platforms for spatiotemporal RNA m<sup>5</sup>C editing. [PDF]
Xu J +14 more
europepmc +1 more source
Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer. [PDF]
He C +10 more
europepmc +1 more source
m5C and m6A cooperatively stabilize EPHB4 to drive lymphatic metastasis in gastric cancer. [PDF]
Zhang Y, He R, Lin X, Ye J.
europepmc +1 more source
RNA methylation as a leukemia stem cell vulnerability. [PDF]
Zhou F.
europepmc +1 more source
A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma. [PDF]
Zheng L +13 more
europepmc +1 more source
Role of RNA 5‑methylcytosine modification in cancer: Insights from coding and non‑coding RNAs (Review). [PDF]
Jiang Q, Gong Y, Zhai M, Tang T, Liu S.
europepmc +1 more source
Correction to "[NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB-STAT3 signalling in a non-m5C manner]". [PDF]
europepmc +1 more source
m<sup>5</sup>C RNA modification in gastrointestinal cancers: a comprehensive review from molecular mechanism to clinical implication. [PDF]
Xu C, Ye Q, Wang H, Yu Y.
europepmc +1 more source
5-Methylcytidine RNA Epitranscriptomics in Women's Health and Disease: Mechanisms and Clinical Implications. [PDF]
Yang Q +6 more
europepmc +1 more source

